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Aims: To determine the susceptibility to visual height intolerance (vHI) in patients with
acquired bilateral vestibulopathy (BVP). The question was whether postural instability in
BVP, which is partially compensated for by visual substitution of the impaired vestibular
control of balance, leads to an increased susceptibility. This is of particular importance
since fear of heights is dependent on body posture, and visual control of balance at
heights can no longer substitute vestibular input. For comparison susceptibility to vHI
was determined in patients with other vestibular or functional disorders.
Methods: A total of 150 patients aged 18 or above who had been referred to the German
Center for Vertigo and Balance Disorders and diagnosed to have BVPwere surveyed with
a standardized questionnaire by specifically trained neurological professionals. Further,
481 patients with other vestibular or functional disorders were included.
Results: Susceptibility to vHI was reported by 29% (32 % in females, 25% in males) of
the patients with BVP. Patients with vHI were slightly younger (67 vs. 71 years). Seventy
percent of those with vHI reported avoidance of climbing, hiking, stairs, darkness, cycling
or swimming (84% of those without vHI). Mean age for onset of vHI was 40 years.
Susceptibility to vHI was higher in patients with other vertigo disorders than in those
with BVP: 64% in those with phobic postural vertigo, 61% in vestibular migraine, 56%
in vestibular paroxysmia, 54% in benign paroxysmal positional vertigo, 49% in unilateral
vestibulopathy and 48% in Menière’s disease.
Conclusions: The susceptibility to vHI in BVP was not higher than that of the
general population (28%).This allows two explanations that need not be alternatives
but contribute to each other: (1) Patients with a bilateral peripheral vestibular deficit
largely avoid exposure to heights because of their postural instability. (2) The irrational
anxiety to fall from heights triggers increased susceptibility to vHI, not the objective
postural instability. However, patients with BVP do not exhibit increased comorbid anxiety
disorders. This view is supported by the significantly increased susceptibility to vHI in
other vestibular syndromes, which are characterized by an increased comorbidity of
anxiety disorders.
Keywords: bilateral vestibulopathy, vestibular migraine, Menière’s disease, benign paroxysmal positional vertigo,
phobic postural vertigo, visual height intolerance
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INTRODUCTION
Historical View on Mechanisms of Fear of
Heights Associated With Postural
Imbalance
A short historical excursus may be permitted here as to
the dependence of fear of heights on posture, locomotion,
and balance control, all of which are affected by bilateral
vestibulopathy. There is phylogenetic evidence of an inborn
behavioral pattern allowing us to perceive and avoid heights,
the so-called “visual cliff” phenomenon. This broadly gene-
linked avoidance of depths in order to prevent falls off cliffs was
comprehensively studied byWalk et al. (1), Walk and Gibson (2).
The innate ability of pre-walking and walking infants to visually
avoid a brink (3, 4) was further supported by animal experiments
in a number of other species including chicks, rats, kittens,
and goats. There are two visual signs for perceiving height as a
special case of distance: the drop-off increases in texture density
beyond the edge, and the absolute and relative motion parallax
cues differ during active locomotion and head movements. Both
texture/density preferences (5, 6) and motion parallax cues are
utilized and interact with each other.
Therefore, it is not surprising that our ancestors were
well aware of visual height intolerance. There are numerous
descriptions of provoking situations and typical symptoms in
the Greek, Roman, and Chinese classics which suggest visual
height intolerance and fear of heights (7). One example is found
in Titus Livius’s history on the second Punic war, where he
describes how soldiers on high ladders plunged to the ground
when attacking Carthago Nova because the heights “had veiled
their eyes with dizziness.” Another example is Hannibal’s
crossing of the Alps in the third century BC. Silius Italicus
recounted this feat in Punica, describing how “the gaze became
dizzy on the high rocks” (8). In the Chinese classic Huangdi
Neijing, the Yellow Thearch is said to suffer from a confusion
and to feel dizzy when he climbed up on to an observation
platform (9). It is interesting that several historical sources
report stance and gait being disturbed. Demokles, for example,
experienced a “slackening of the muscles of the entire body”
(Greek Corpus Hippocraticum fifth century BC) when walking
along the edge of a precipice or over a bridge; however, he
would dare to walk in the ditch itself. Similarly Phaeton turned
pale while driving the sun chariot (Ovid’s Metamorphoses,
about 0–8 AD) and suddenly felt his knees trembling from
fear (8). Later the main ouvre of Erasmus Darwin, Zoonomia,
or The Laws of Organic Life in 1794 (10), also provided a
detailed early concept of disturbed sensorimotor control when
exposed to heights. The Yellow Thearch in ancient China
intuitively found a treatment, namely kneeling on the ground:
it alleviated the symptoms that had occurred at heights while
he stood on an observation platform. This historical “antidote”
corresponds to contemporary psychophysical experiments
(11, 12).
The mechanism that explains a physiological postural
imbalance at heights is separate and distinct from that caused
by purely cognitive reasons or anxiety as earlier researchers like
Purkinje in 1820 (13) emphasized. A geometrical consideration
reveals the mechanism of physiological postural imbalance at
heights. In order to be visually detected, body sway must increase
with increasing distance between the eyes and the stationary
contrasts in the environment, because angular displacement of
the surroundings on the retina is smaller, the greater the distance
to them (11, 12, 14). Head sway is no longer visually detected by
retinal slip (which is subthreshold) when the distance between
the eyes and stationary contrasts exceeds about 3 meters. Then
head and body sway rely solely on vestibular and somatosensory
input. Hence, visual stabilization of posture is impaired and
instability increases in the fore-aft and lateral planes. This causes
an unsteadiness that increases the danger of falling (11, 14)
(Figure 1).
Further analyses were performed under real stimulus
conditions while subjects with visual height intolerance stood
on a force-measuring platform. Major results were that open-
loop control was disturbed by a higher diffusion activity, and the
sensory feedback threshold for closed-loop control was lowered.
This was predominantly associated with increased co-contraction
of the leg muscles (15, 16). Walking in these subjects is slow
and cautious, broad-based, and consists of small, flat-footed steps
with less dynamic vertical oscillations of the body and head
(12, 17).
The non-medical Anglo-American community uses a single
term “fear of heights” to refer to a more-or-less severe visual
height intolerance that, however, does not generally fulfill the
criteria of the specific phobia “acrophobia.” On the basis of
the above-described findings we proposed in an earlier study
to distinguish between three terms in order to resolve possible
confusion about physiological and pathological (psychiatric)
mechanisms active during exposure to heights (18): (1) An
imbalance of stance and gait at heights caused by impaired visual
control. This is physiological and has no clinical relevance; (2) A
visual height intolerance, which is more or less distressing and
has clinical relevance for about one half of those susceptible;
(3) Fear of heights or acrophobia, defined as a specific phobia
in psychiatry (19, 20) which requires psychotherapy (7). In our
study which was based on a questionnaire we did not differentiate
between visual height intolerance and acrophobia, instead used
visual height intolerance (vHI) as the umbrella term.
Why Investigate Susceptibility to vHI in
Bilateral Vestibulopathy and Other
Vestibular Disorders?
The major question of the current study, i.e., whether bilateral
vestibulopathy (BVP) is a trigger of vHI (7), is related to an
impaired balance in both conditions. Thus, postural instability
in BVP could act as a trigger of vHI. More specifically, there
were three reasons which prompted us to investigate a potential
increase in susceptibility of patients with BVP to vHI:
1) The loss of vestibular function causes not only oscillopsia
during locomotion, but also unsteadiness of stance and gait.
This unsteadiness is partially compensated for by visual
substitution of the impaired vestibular control of postural
balance.
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FIGURE 1 | The mechanism of a physiological postural imbalance at visual heights can be explained by the dependence of the retinal slip of viewed objects on their
distance. This is depicted schematically (Top). Visual control of body sway in fore-aft, lateral, and roll planes shows that angular displacement on the retina caused by
fore-aft and lateral head displacements are smaller, the greater the distance is to the object. Therefore, when exposed to heights, the head sway goes visually
undetected (the retinal slip is below the threshold value for detecting motion) and thus impairs visual stabilization of posture. This is different for head and body sway in
the roll plane (Bottom right of the Top figure). In this plane, the distance between eyes and fixated objects has no influence on the net retinal slip. Original traces of the
fore-aft and lateral body sway with the eyes closed, eyes open in front of a wall shows the stabilizing effect of posture (Bottom, figure left). Viewing from a balcony
with the eyes open impairs fore-aft and lateral body sway since the retinal slip of the viewed environment is subthreshold. However, with additional stationary contours
of the balcony in the peripheral visual field the visual stabilization of posture is restored (Bottom, figure right). The influence of head movements in the frontal roll plane
on postural control was not measured in the experiment. However, as stated above, retinal slip is independent of the viewing distance for head and eye movements in
roll [modified from (15, 16)].
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2) Visual control of balance, however, is impaired at
substantial heights. When stationary targets are viewed
from distant/remote heights, the retinal slip of the image falls
below the threshold value at which head and body sway can
no longer be detected (Figure 1).
3) Balance is further impaired by an associated sensory
polyneuropathy, which is found in about 25% of the mostly
elderly patients with BVP. It also occurs with associated
cerebellar symptoms in 25% of these patients, (21), in part
overlapping. It has been shown that the combination of BVP
and polyneuropathy particularly increases instability of stance
and gait, which leads to frequent falls in darkness and/or on
uneven ground (22).
All three reasons make it likely that patients with BVP adjust
their behavior in order to avoid experiencing visual heights, since
balance control puts special demands on this condition.
The occurrence of vHI is clearly related to body position. It is
strongest during erect stance, when maintaining balance is most
difficult, less severe when kneeling down or sitting, and minimal
or absent when the subject is lying while looking down (11). This
is supported by the experiences of airplane passengers, who do
not complain about having vHI.
The current study on the effects of BVP and other vestibular
and functional disorders of vertigo and balance on the
susceptibility to vHI is based on a standardized questionnaire
applied to patients who were examined as outpatients in the
German Centre for Vertigo and Balance Disorders (DSGZ).
METHODS
Patients and Data Collection
A total of 150 patients with complete or asymmetrically
incomplete loss of peripheral vestibular function were
surveyed. Further, 481 patients with other vestibular or
somatoform/functional disorders were included for comparison:
vestibular migraine (n= 51), Menière’s disease (n= 112), benign
paroxysmal positional vertigo (n = 97), vestibular paroxysmia
(n= 25), unilateral vestibulopathy (n= 94), and phobic postural
vertigo (functional dizzines) (n = 102). Patients were included
if they were aged 18 or above and had been referred to the
DSGZ. All patients received a complete neurological, neuro-
ophthalmological, and neuro-otological examination by experts
in neuro-otology. Data were extracted from clinical patient
records and the specific questionnaires.
Inclusion Criteria
The diagnosis of BVP was based on the patient history as well
as bedside and laboratory examinations. Patients complained
of unsteadiness when walking or standing, which worsened in
darkness and/or on uneven ground, but had no such symptoms
while sitting or lying down under static conditions. Laboratory
examinations revealed a bilaterally reduced or absent angular
vestibulo-ocular reflex (VOR; VOR gain <0.6 on both sides)
(indicating a high frequency deficit of the VOR) and bilaterally
diminished (mean peak slow-phase velocity <5 deg/s on both
sides) or absent nystagmus responses to caloric irrigation
(indicating a low frequency deficit). These criteria largely
correspond to the recently published Consensus Document of
the Classification Committee of the Bárány Society (23). The
diagnosis of the other vestibular and functional disorders of
vertigo and balance was also based on the criteria of the
classification committee of the Bárány Society (24–29). All
patients had given their informed consent.
Exclusion Criteria
Exclusion criteria were other disorders of stance and gait,
cognitive impairment, psychiatric disorders, severe visual loss,
chronic medication with sedatives or drug/substance abuse.
Questionnaires
Susceptibility and characteristics of vHI were ascertained by a
questionnaire containing questions to symptoms, triggers, course
of the condition, and compensational behavior (30). It had
been adapted and extended to include patients with BVP and
other vestibular and functional disorders by adding questions on
quality of life, physical and sporting activities, social functioning,
avoidance behavior, and motion sickness susceptibility.
The German version of the Dizziness Handicap Inventory
(DHI) was used in 49 of the 150 patients with BVP to evaluate
vertigo-specific functioning (31). The DHI consists of 25 items
that can be grouped into three domains representing functional,
emotional and physical aspects. A total score is obtained by
summing each ordinal scaled response. The total score ranges
from 0-100 points; higher scores indicate amore severe handicap.
The sub-domains consist of seven physical items, nine functional
items, and nine emotional items.
Statistics
Differences were tested using Student’s t-Tests for numerical
and Chi-Square Tests for categorical variables on an explorative
testwise alpha level of 0.05. SAS V9.4 for Windows 10 was used
for all analyses.
RESULTS
Of the 150 patients with a verified diagnosis of BVP (mean age
70.0, 47% females, 31% academics) vHI was reported by 29%
(females 32%, males 25%; see Table 1). Of those with vHI 70%
reported avoidance of climbing, hiking, stairs, darkness, cycling,
swimming, or skiing (84% of those without vHI). Patients with
vHI were not significantly younger (67 vs. 71 years, p = 0.165)
and had had a significantly earlier lifetime onset of BVP (58 vs.
64 years, p = 0.031). Mean age for onset of vHI was 40 years.
Among persons with polyneuropathy, 21% had vHI (31% of
those without polyneuropathy had vHI); among persons with
migraine, 32% reported vHI (28% without migraine); among
persons with motion sickness, 45% reported vHI (26% without
motion sickness).
Sixteen percent of all BVP patients had one or more
family members with vHI (3—parents, 3—siblings, 1—children).
Anxiety, panic attacks, or any phobia was present in 11% of
all BVP patients. Among those with anxiety, vHI was reported
by 41%. Climbing a tower was the most frequent first trigger
for vHI, followed by climbing a ladder or looking out of the
window of a high building; 35% (15/43) reported they avoid
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TABLE 1 | Frequency of vHI, migraine, motion sickness, anxiety, polyneuropathy,
and fear or panic in patients with BVP.
Visual height intolerance in
those with BVP
Total No Yes
N N % N %
AGE GROUP
<30 2 2 100.0 0 0
30–39 2 1 50.0 1 50.0
40–49 5 2 40.0 3 60.0
50–59 21 14 66.7 7 33.3
60–69 29 20 69.0 9 31.0
70–79 56 40 71.4 16 28.6
80+ 35 28 80.0 7 20.0
SEX
Male 79 59 74.7 20 25.3
Female 71 48 67.6 23 32.4
MIGRAINE
No 125 90 72.0 35 28.0
Yes 25 17 68.0 8 32.0
MOTION SICKNESS
No 130 96 73.8 34 26.2
Yes 20 11 55.0 9 45.0
PHOBIA/ANXIETY
No 141 100 70.9 41 29.1
Yes 9 7 77.8 2 22.2
POLYNEUROPATHY
No 59 41 69.5 18 30.5
Yes 33 26 78.8 7 21.2
Total 150 107 71.3 43 28.7
hiking in the mountains (this was identical in BVP patients
without vHI), 9% (4/43) avoid this because of vHI. Further details
on specific symptoms (such as swaying vertigo, inner agitation,
trembling, diffuse sweating) concerning vHI attacks and the
manifestation of BVP as well as its time-course since then are
not reported here for two reasons: first, the limitation of the
reliability of these details collected in a printed questionnaire,
and second, because most patients with BVP cannot determine
the exact date and time-course of the bilateral vestibular
failure.
Patients with vHI scored higher on the DHI total (46.8 vs.
39.7), but the difference was not significant. We did not see any
significant differences in instrumental measures between patients
with and without vHI.
Susceptibility to vHI was higher in patients with other
disorders of vertigo and balance than in BVP patients
(Table 2): Prevalence of vHI was 64% in patients with phobic
postural vertigo, 61% in vestibular migraine, 56% in vestibular
paroxysmia, 54% in benign paroxysmal positional vertigo, 49%
in unilateral vestibulopathy, and 48% in Menière’s disease. As
depicted in Table 3 these disorders were also associated with an
TABLE 2 | Frequency of vHI in benign paroxysmal positional vertigo (BPPV),
bilateral vestibulopathy (BVP), functional dizziness/phobic postural vertigo,




N N % N %
DIAGNOSIS
BPPV 97 45 46.4 52 53.6
BVP 150 107 71.3 43 28.7
Functional dizziness 102 37 36.3 65 63.7
Menière’s disease 112 58 51.8 54 48.2
UVP 94 48 51.1 46 48.9
Vest. migraine 51 20 39.2 31 60.8
Vest. paroxysmia 25 11 44.0 14 56.0
Total 631 326 51.7 305 48.3
TABLE 3 | Frequency of fear or panic in seven disoreders of vertigo and balance
(benign paroxysmal positional vertigo (BPPV), bilateral vestibulopathy (BVP),
functional dizziness/phobic postural vertigo, Menière’s disease, unilateral
vestibulopathy (UVP), vestibular migraine, and vestibular paroxysmia.
Fear or Panic
Total No Yes
N N % N %
DIAGNOSIS
BPPV 97 76 78.4 21 21.6
BVP 150 133 88.7 17 11.3
Functional dizziness 102 64 62.7 38 37.3
Menière’s disease 112 91 81.3 21 18.8
UVP 94 73 77.7 21 22.3
Vest. migraine 51 36 70.6 15 29.4
Vest. paroxysmia 25 20 80.0 5 20.0
Total 631 493 78.1 138 21.9
increased frequency of fear or panic ranging from 20 to 37%,
whereas in BVP it only amounted to 11%.
DISCUSSION
Visual Height Intolerance and Bilateral
Vestibulopathy
The survey did not support our expectation that BVP patients
would have a heightened susceptibility to vHI. We found that
the overall susceptibility to visual height intolerance of varying
severity including acrophobia was not significantly higher than
that for the general German population.
Patients with BVP indicated a current susceptibility rate of
29% (in females 32%, in males 25%), whereas the life-time
prevalence in the general population is 28% (in females 32%, in
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TABLE 4 | Comparison of the life-time prevalence of visual height intolerance (vHI)
drawn from a cross-sectional epidemiological study on 3,517 individuals (middle
column, 15) and the reported susceptibility to vHI in patients with acquired BVP
(right column) depicted for age groups from below 30 to above 60 years.
Age group From Huppert et al. (32) Patients with BVP
<30 29% (144/495) 0% (0/2)
30–39 28% (117/417) 50% (1/2)
40–49 31% (214/691) 60% (3/5)
50–59 33% (230/698) 33% (7/21)
>=60 25% (304/1216) 26% (32/121)
males 25%) (30). The value of comparing different age groups
(Table 4) is limited because of the lower random sample of the
current study.
The characteristics of the development and course of BVP
did not allow us to correlate the pronounced variations in vHI
susceptibility with disease onset and the severity of BVP. The
onset of BVP may be abrupt as in meningitis or after intake
of ototoxic antibiotics, or stepwise for each ear as in Menière’s
disease, or slowly progressive as in the majority of cases with
degenerative or “idiopathic” etiology (21, 32). In the patients
with associated polyneuropathy and/or cerebellar symptoms,
conditions that further increase postural instability, we did not
find an enhanced susceptibility to vHI. The specific triggers of
vHI are the same in patients with and without BVP: climbing
a tower was the most frequent first trigger for vHI, followed by
climbing a ladder or looking out of the window of a high building.
These results are surprising, since the occurrence and severity
of vHI and acrophobia critically depend on body position.
Visual height intolerance is strongest during free upright
stance at heights when the major concern and anxiety of the
individual is to fall (11, 14). Several studies have focused on
postural instability in patients with BVP, in particular if visual
and/or proprioceptive substitution of the diminished/absent
vestibular input is experimentally impaired (33) and also when
virtual reality stimulation is used (34). Gait analysis of BVP
patients walking on a pressure-sensitive carpet revealed that
especially increased gait fluctuations during slow walking are
most predictive of an increased fall risk (22). This study also
found that a sensory polyneuropathy further critically impairs
postural instability. A controlled cross-sectional study reported
that the rate of recurrent fallers was 30% in patients with
BVP and associated polyneuropathy (35). This increases fear
of falling, deteriorates quality of life and negatively impacts
on physical and social functioning (36). Our study showed
that a considerable percentage avoided potentially dangerous
situations, e.g., cycling, walking in the dark and hiking. Thus,
contrary to our expectations patients with BVP did not exhibit
an increased susceptibility to vHI. Possible explanations are
discussed below in the Conclusions.
Another finding of our survey was that some patients
with BVP may still experience motion sickness: 10% in BVP
patients and 21% in patients with BVP and vHI. This seemingly
disagrees with findings of various animal experiments in dogs
and monkeys and observations in humans: namely, that motion
sickness no longer occurred in any species following bilateral
vestibular loss (37–39). It is conceivable that residual vestibular
function in incomplete BVPmay be responsible for the preserved
susceptibility to motion sickness (40).
Limitations
A study just based on filling out a printed questionnaire has
several limitations as to the reliability of the data on triggers,
symptoms, and time-course of vHI. The used questionnaire
does not allow us to differentiate between vHI and the
specific phobia fear of heights. In the meantime such a
questionnaire has been developed (41) which was not available
at the time of the study. Furthermore, the onset of BVP
remains particularly unclear for most patients since it may
be abrupt (i.e., secondary to ototoxic antibiotics) or slowly
progressive and asymmetric, involving one ear in the beginning
with subsequent involvement of the second ear. Therefore we
concentrated on the overall frequency of vHI rather than trying
to statistically correlate detailed statements provided by the
questionnaire. Experimental ideas initiated by the study results
would be systematic quantitative analyses of posture and gait
in patients with BVP with and without vHI under natural
stimulus conditions at heights at which vision can no longer
substitute for the lack of vestibular information for balance
control.
CONCLUSIONS
Our finding that BVP does not increase susceptibility to vHI
can be interpreted in two ways. First, one could argue that
patients with this sensory deficit actively avoid exposure to
heights (84% of BVP patients without vHI and 70% with vHI
avoid climbing, hiking, stairs, darkness, cycling, swimming, or
skiing). It is, however, very difficult to avoid stimuli when
they are ubiquitous, e.g., staircases, balconies, bridges. Second,
the objective postural instability is not the major trigger of
an increased susceptibility to heights, but rather the irrational
subjective anxiety at heights is the major trigger. It is well
known that there are links between vestibular disorders, balance
control, and anxiety. Based on pathways that mediate vestibular-
autonomic interactions and anxiety, these links involve the
parabrachial nucleus and its reciprocal interconnections with the
amygdaloid nucleus, infralimbic cortex, and the hypothalamus
(42). Several experiments have supported this, showing that
susceptible subjects walk in a cautious way, both when visually
exposed to heights as well as when only aware of heights but
not visually exposed (17, 43) or during virtual reality stimulation
[used in acrophobia research and treatment; (44)]. In a case-
control study a representative sample of 2,012 individuals was
surveyed in which acrophobia was associated with high rates
of comorbid, anxious, and depressive disorders; migraine was
also a significant predictor of acrophobia (45). With respect
to our current study, the argument that increased anxiety
is a trigger of vHI in patients with BVP is not supported
by the findings of a study on psychiatric comorbidity in
patients with various vestibular disorders. It revealed that
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anxiety/phobic disorders were less in BVP than in vestibular
migraine, Menière’s disease, vestibular paroxysmia, or benign
paroxysmal positional vertigo (46). Our data confirm this
psychiatric comorbidity (Table 3). Obviously in BVP anxiety is
low because vestibular-autonomic interaction is reduced due to
the lack of vestibular input. Both above-described interpretations
need not be alternative explanations but may contribute to each
other.
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